AKT1 and breast cancer: Moreover, miR-7-5p, which has been reported to be involved in PI3K/Akt signaling pathway activation and chemoresistance in BC [120], was predicted to be a target of circ_0006528, while Raf1, a MAPK signaling pathway activator, is a direct target of miR-7-5p [121].